Decopharma has been acquired by CTT
Heinäkuuta 2025 — Decopharma has been acquired by CTT – Correios de Portugal, strengthening its position as a national reference in pharmaceutical logistics solutions. This strategic transaction marks an important step in the consolidation of the specialized logistics sector in Portugal, combining Decopharma’s expertise in healthcare logistics with CTT’s robust infrastructure and growth potential.
Decopharma provides end-to-end logistics services for the pharmaceutical and healthcare sectors, covering medicines such as over-the-counter products (OTC), nutraceuticals, cosmetics and veterinary items, as well as medical devices including hospital equipment, consumables and laboratory supplies. With a team of around 30 employees, the company manages the entire logistics chain — from goods reception and storage to quality control, order processing and distribution.
CTT – Correios de Portugal is a leading provider of integrated logistics and distribution services, offering parcel delivery, express shipping and e-commerce solutions. Backed by a nationwide infrastructure and specialized subsidiaries like CTT Expresso, the company enables efficient last-mile delivery and supply chain operations for businesses across various sectors.
Roolimme transaktiossa
Oaklins’ team in Portugal advised the shareholders of Decopharma in this transaction.
Ota yhteyttä transaktiotiimiin
Transaktiot
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Lue lisääMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Lue lisääQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Lue lisää